These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1836980)

  • 1. Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis.
    Leslie CA; Robertson MW; Cutler AJ; Bennett JP
    Brain Res Dev Brain Res; 1991 Sep; 62(1):109-14. PubMed ID: 1836980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution.
    Caboche J; Rogard M; Besson MJ
    Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS; Joyce JN
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development.
    Duncan GE; Breese GR; Criswell HE; Johnson KB; Schambra UB; Mueller RA; Caron MG; Fremeau RT
    J Neurochem; 1993 Oct; 61(4):1255-62. PubMed ID: 8376983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 6-hydroxydopamine lesions of the medial prefrontal cortex on local cerebral blood flow and D1 and D2 dopamine receptor binding in rats: a quantitative autoradiographic study.
    Suzuki M; Kawasaki Y; Murata M; Shibata R; Kurachi M; Mori H
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):95-101. PubMed ID: 7549461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented sensitivity of D1-dopamine receptors in lateral but not medial striatum after 6-hydroxydopamine-induced lesions in the neonatal rat.
    Simson PE; Johnson KB; Jurevics HA; Criswell HE; Napier TC; Duncan GE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1454-63. PubMed ID: 1361576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study.
    Tarazi FI; Tomasini EC; Baldessarini RJ
    Dev Neurosci; 1999; 21(1):43-9. PubMed ID: 10077701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum.
    Mayfield RD; Larson G; Zahniser NR
    Brain Res; 1992 Feb; 573(2):331-5. PubMed ID: 1387030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex.
    Stevenson CW; Gratton A
    Eur J Neurosci; 2003 Mar; 17(6):1287-95. PubMed ID: 12670317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J; Lindqvist E; Young D; Cowburn R
    Exp Brain Res; 1990; 83(1):85-95. PubMed ID: 1981564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
    Neal BS; Joyce JN
    Brain Res Dev Brain Res; 1991 Jun; 60(2):105-13. PubMed ID: 1832593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dcc haploinsufficiency regulates dopamine receptor expression across postnatal lifespan.
    Pokinko M; Grant A; Shahabi F; Dumont Y; Manitt C; Flores C
    Neuroscience; 2017 Mar; 346():182-189. PubMed ID: 28108253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.